Skip Navigation
Skip to contents

JPTM : Journal of Pathology and Translational Medicine


Author index

Page Path
HOME > Articles and issues > Author index
Khairunisa Ahmad Affandi 1 Article
p40 Immunohistochemistry Is an Excellent Marker in Primary Lung Squamous Cell Carcinoma
Khairunisa Ahmad Affandi, Nur Maya Sabrina Tizen, Muaatamarulain Mustangin, Reena Rahayu MdReena Rahayu Md Zin
J Pathol Transl Med. 2018;52(5):283-289.   Published online August 31, 2018
  • 15,174 View
  • 252 Download
  • 13 Citations
AbstractAbstract PDF
Lung cancer is the third most common cancer worldwide. With major advances in the molecular testing of lung cancers and the introduction of targeted therapies, the distinction between adenocarcinoma and squamous cell carcinoma as well as pathologic subtyping has become important. Recent studies showed that p40 is highly specific for squamous and basal cells and is superior to p63 for diagnosing lung squamous cell carcinoma. The aim of this study was to evaluate the use of p40 immunohistochemical stain in the diagnosis of non-small cell lung carcinoma and its potential to replace current p63 antibody as the best immunohistochemical squamous marker.
Seventy formalin-fixed paraffin-embedded cases previously diagnosed as primary lung squamous cell carcinoma (n = 35) and lung adenocarcinoma (n = 35) from January 2008 to December 2016 were retrieved. The results of tumour cell immunoreactivity for p40 and p63 antibodies in lung squamous cell carcinoma and lung adenocarcinoma were compared.
p40 was expressed in 27 cases of lung squamous cell carcinoma (77.1%). All cases of lung adenocarcinoma (35/35, 100%) were negative for p40. p63 expression was positive in 30 cases of lung squamous cell carcinoma (85.7%) and 13 cases of lung adenocarcinoma (37.1%). Reactivity for both p40 and p63 in lung squamous cell carcinoma was strong and diffuse, whereas variable reactivity was observed in lung adenocarcinoma.
p40 is an excellent marker for distinguishing lung squamous cell carcinoma from adenocarcinoma, and p40 expression is equivalent to p63 expression in lung squamous cell carcinoma.


Citations to this article as recorded by  
  • A targeted expression panel for classification, gene fusion detection and PD-L1 measurements – Can molecular profiling replace immunohistochemistry in non-small cell lung cancer?
    Anita Tranberg Simonsen, Amalie Utke, Johanne Lade-Keller, Lasse Westphal Thomsen, Torben Steiniche, Magnus Stougaard
    Experimental and Molecular Pathology.2022; 125: 104749.     CrossRef
  • Basal cell carcinoma arising in association with maxillary odontogenic keratocyst in a patient with Gorlin-Goltz syndrome
    Mutsuki Kawabe, Yoshitane Tsukamoto, Shohei Matuo, Shuji Kanda, Susumu Hashitani
    Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.2022; 34(3): 333.     CrossRef
  • Cutaneous Metastases from Thymic Carcinoma Primary Tumor: A Rare Case
    Eva Krishna Sutedja, Trustia Rizqandaru, Kartika Ruchiatan, Endang Sutedja
    International Medical Case Reports Journal.2022; Volume 15: 293.     CrossRef
  • Primary nonkeratinizing squamous cell carcinoma of the scapular bone: A case report
    Yang Li, Jian-Lin Zuo, Jin-Shuo Tang, Xian-Yue Shen, Sheng-Hao Xu, Jian-Lin Xiao
    World Journal of Clinical Cases.2021; 9(4): 976.     CrossRef
  • Survival-associated N6-adenosine methyltransferase signatures in lung squamous cell carcinoma and clinical verification
    Jialin Qu, Li Wang, Man Jiang, Zhimin Wei, Guangming Fu, Xiaochun Zhang
    BMC Cancer.2021;[Epub]     CrossRef
  • Pulmonary adenomyoma presenting as a right cardiophrenic angle mass
    Osigbemhe Iyalomhe, Sam Sadigh, Charuhas Deshpande, Leslie Litzky, Anna Moran, Scott Simpson
    Radiology Case Reports.2020; 15(5): 502.     CrossRef
  • Head-to-Head Comparison of p63 and p40 in Non-Neuroendocrine Carcinomas of the Tubal Gut
    Ahmed M. Bakhshwin, Ilyssa O. Gordon, Kathryn Bock Brown, Xiuli Liu, Daniela S. Allende
    International Journal of Surgical Pathology.2020; 28(8): 835.     CrossRef
  • Greater specificity of p40 compared with p63 in distinguishing squamous cell carcinoma from adenocarcinoma in effusion cellblocks
    Nah Ihm Kim, Ji Shin Lee
    Cytojournal.2020; 17: 13.     CrossRef
  • Incidental Thyroid Mass in a Patient With Oropharyngeal Squamous Cell Carcinoma
    Kinneri Mehta, Misha Movahed-Ezazi, Akshay V. Patel
    JAMA Otolaryngology–Head & Neck Surgery.2020; 146(9): 859.     CrossRef
  • Three dimensional texture analysis of noncontrast chest CT in differentiating solitary solid lung squamous cell carcinoma from adenocarcinoma and correlation to immunohistochemical markers
    Rui Han, Roshan Arjal, Jin Dong, Hong Jiang, Huan Liu, Dongyou Zhang, Lu Huang
    Thoracic Cancer.2020; 11(11): 3099.     CrossRef
  • The role of the immunohistochemical marker p40 in the differential diagnosis of adenocarcinoma and nonkeratinizing squamous cell cancer of the lung
    E.M. Olyushina, M.M. Byakhova, L.E. Zavalishina, Yu.Yu. Andreeva, A.B. Semenova, G.A. Frank
    Arkhiv patologii.2020; 82(5): 50.     CrossRef
  • Role of Immunocytochemistry in the Cytological Diagnosis of Pulmonary Tumors
    Jasna Metovic, Luisella Righi, Luisa Delsedime, Marco Volante, Mauro Papotti
    Acta Cytologica.2020; 64(1-2): 16.     CrossRef
  • Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies
    Nunes, Diniz, Moreira-Barbosa, Constâncio, Silva, Oliveira, Soares, Paulino, Cunha, Rodrigues, Antunes, Henrique, Jerónimo
    Journal of Clinical Medicine.2019; 8(9): 1500.     CrossRef

JPTM : Journal of Pathology and Translational Medicine